DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $167,463,530 | +0.1% | 674,984 | -3.2% | 0.39% | +6.2% |
| Q2 2023 | $167,286,480 | -6.6% | 697,027 | -2.0% | 0.37% | -10.8% |
| Q1 2023 | $179,197,668 | -5.8% | 710,989 | -0.7% | 0.42% | -10.7% |
| Q4 2022 | $190,130,698 | +1.1% | 716,339 | -1.6% | 0.47% | -3.5% |
| Q3 2022 | $188,037,000 | +2.0% | 728,009 | +0.1% | 0.48% | +8.3% |
| Q2 2022 | $184,432,000 | -17.0% | 727,484 | -4.0% | 0.45% | +3.7% |
| Q1 2022 | $222,248,000 | -12.2% | 757,672 | -1.6% | 0.43% | -5.5% |
| Q4 2021 | $253,229,000 | +7.9% | 769,670 | -0.1% | 0.46% | -0.4% |
| Q3 2021 | $234,585,000 | +10.8% | 770,547 | -2.3% | 0.46% | +14.2% |
| Q2 2021 | $211,738,000 | +16.2% | 789,009 | -2.5% | 0.40% | +10.2% |
| Q1 2021 | $182,180,000 | -2.8% | 809,402 | -4.1% | 0.36% | -4.5% |
| Q4 2020 | $187,398,000 | +1.4% | 843,603 | -1.7% | 0.38% | -9.5% |
| Q3 2020 | $184,778,000 | +21.5% | 858,115 | -0.2% | 0.42% | +11.7% |
| Q2 2020 | $152,079,000 | +27.8% | 860,028 | +0.1% | 0.38% | +3.9% |
| Q1 2020 | $118,975,000 | -6.6% | 859,585 | +3.6% | 0.36% | +16.4% |
| Q4 2019 | $127,393,000 | +5.1% | 830,033 | -1.1% | 0.31% | -1.9% |
| Q3 2019 | $121,247,000 | +1.0% | 839,483 | -0.1% | 0.32% | +1.6% |
| Q2 2019 | $120,081,000 | +6.4% | 840,198 | -1.7% | 0.31% | +4.0% |
| Q1 2019 | $112,839,000 | +29.1% | 854,712 | +0.9% | 0.30% | +14.9% |
| Q4 2018 | $87,395,000 | -5.1% | 847,506 | +0.0% | 0.26% | +11.5% |
| Q3 2018 | $92,057,000 | +9.0% | 847,204 | -1.0% | 0.23% | +3.5% |
| Q2 2018 | $84,487,000 | +0.9% | 856,175 | +0.1% | 0.23% | -1.7% |
| Q1 2018 | $83,747,000 | +2.2% | 855,351 | -3.1% | 0.23% | +5.5% |
| Q4 2017 | $81,956,000 | +8.9% | 882,961 | +0.7% | 0.22% | +6.3% |
| Q3 2017 | $75,236,000 | +2.8% | 877,076 | +1.2% | 0.20% | -0.5% |
| Q2 2017 | $73,171,000 | -1.3% | 867,056 | +0.1% | 0.21% | -3.7% |
| Q1 2017 | $74,112,000 | +9.0% | 866,506 | -0.8% | 0.21% | +4.4% |
| Q4 2016 | $67,963,000 | +0.1% | 873,111 | +0.8% | 0.20% | -3.3% |
| Q3 2016 | $67,926,000 | -22.0% | 866,517 | +0.4% | 0.21% | -23.5% |
| Q2 2016 | $87,129,000 | +24.4% | 862,666 | +16.9% | 0.28% | +4.1% |
| Q1 2016 | $70,013,000 | +1.2% | 738,063 | -0.9% | 0.27% | +3.1% |
| Q4 2015 | $69,149,000 | +6.8% | 744,503 | -2.0% | 0.26% | +3.2% |
| Q3 2015 | $64,720,000 | -1.2% | 759,532 | -0.8% | 0.25% | +7.8% |
| Q2 2015 | $65,500,000 | -1.6% | 765,276 | -2.4% | 0.23% | +2.2% |
| Q1 2015 | $66,539,000 | -7.9% | 783,732 | -7.0% | 0.23% | 0.0% |
| Q4 2014 | $72,251,000 | +10.9% | 842,967 | -1.7% | 0.23% | +7.1% |
| Q3 2014 | $65,174,000 | -7.0% | 857,773 | -3.6% | 0.21% | -4.5% |
| Q2 2014 | $70,051,000 | +4.8% | 889,763 | -0.2% | 0.22% | +2.3% |
| Q1 2014 | $66,843,000 | -13.1% | 891,239 | -10.6% | 0.22% | -6.1% |
| Q4 2013 | $76,939,000 | +10.0% | 996,625 | -1.3% | 0.23% | +2.2% |
| Q3 2013 | $69,965,000 | +9.1% | 1,009,309 | -0.4% | 0.23% | +6.1% |
| Q2 2013 | $64,146,000 | – | 1,013,367 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Defender Capital, LLC. | 149,732 | $49,263,000 | 15.79% |
| ARTHUR M. COHEN & ASSOCIATES, LLC | 257,846 | $84,834,000 | 15.76% |
| Riverstone Advisors, LLC | 64,448 | $21,204,000 | 9.33% |
| Eos Focused Equity Management, L.P. | 34,026 | $11,195,000 | 8.72% |
| Mirova US LLC | 1,152,609 | $379,219,000 | 7.12% |
| Lincoln Capital LLC | 83,275 | $27,398,000 | 6.78% |
| CORTLAND ASSOCIATES INC/MO | 197,469 | $64,969,000 | 6.75% |
| Third Point | 2,900,000 | $954,129,000 | 6.66% |
| Front Street Capital Management, Inc. | 117,523 | $36,073,000 | 6.65% |
| Alphinity Investment Management Pty Ltd | 865,427 | $284,734,000 | 6.40% |